Status:
COMPLETED
Primovist Regulatory Post Marketing Surveillance (PMS)
Lead Sponsor:
Bayer
Conditions:
Liver
Eligibility:
All Genders
Brief Summary
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice
Eligibility Criteria
Inclusion
- Patient who take Primovist for liver MRI
Exclusion
- Patients who belong to the contraindication on the product label
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
4358 Patients enrolled
Trial Details
Trial ID
NCT00924248
Start Date
October 1 2007
End Date
May 1 2011
Last Update
September 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, South Korea